UK Renal Registry 18th Annual Report: Chapter 2 UK Renal Replacement Therapy Prevalence in 2014: National and Centre-specific Analyses
UK Renal Registry 18th Annual Report: Chapter 2 UK Renal Replacement Therapy Prevalence in 2014: National and Centre-specific Analyses
复制标题
DOI：
10.1159/000444816
复制
发表时间：
2016-01-01
期刊：
影响因子：
2.5
通讯作者：
Castledine, Clare
中科院分区：
文献类型：
--
作者：
MacNeill, Stephanie J.;Casula, Anna;Castledine, Clare
2014年12月31日，英国有58，968例成人患者接受肾脏替代治疗（RRT），较2013年绝对增加4.0%。血液透析（HD）的实际患者人数增加2.0%，移植功能正常者为5.3%，但腹膜透析（PD）患者下降0.7%。英国成人RRT患病率为每百万人口913例（pmp）。2000年报告的患病率为523 pmp。接受家庭HD的患者数量从2013年的1，113例增加到2014年的1，188例，增加了6.7%。患者的中位年龄为59岁（HD 67岁，PD 64岁，移植53岁）。2000年，中位年龄为55岁（HD 63岁，PD 58岁，移植48岁）。2014年，年龄大于75岁的RRT患者比例为16.0%。对于所有年龄段，男性患病率均超过女性，75-79岁年龄组男性患病率达到峰值，为3，100 pmp，70-74岁年龄组女性患病率为1，600 pmp。最常见的可识别肾脏诊断为肾小球肾炎（19%），其次是糖尿病（16%）和病因不明（16%）。移植仍然是最常见的治疗方式（53%），41%的RRT患者使用HD，6%的RRT患者使用PD。2013年至2014年，585岁患者的患病率继续增加（1，021/百万年龄相关人群（pmarp）至1，060 pmarp）。
There were 58,968 adult patients receiving renal replacement therapy (RRT) in the UK on 31st December 2014, an absolute increase of 4.0% from 2013.The actual number of patients increased 2.0% for haemodialysis (HD), 5.3% for those with a functioning transplant but decreased 0.7% for peritoneal dialysis (PD).The UK adult prevalence of RRT was 913 per million population (pmp). The reported prevalence in 2000 was 523 pmp.. The number of patients receiving home HD increased by 6.7% from 1,113 patients in 2013 to 1,188 patients in 2014.The median age of prevalent patients was 59 years (HD 67 years, PD 64 years, transplant 53 years). In 2000, the median age was 55 years (HD 63 years, PD 58 years, transplant 48 years). In 2014, the percentage of RRT patients aged greater than 75 years was 16.0%.For all ages, the prevalence rate in men exceeded that in women, peaking in age group 75-79 years at 3,100 pmp in men and for women at 1,600 pmp in age group 70-74 years.The most common identifiable renal diagnosis was glomerulonephritis (19%), followed by diabetes (16%) and aetiology uncertain (16%).. Transplantation continued as the most common treatment modality (53%), HD was used in 41% and PD in 6% of RRT patients.Prevalence rates in patients aged 585 years continued to increase between 2013 and 2014 (1,021 per million age related population (pmarp) to 1,060 pmarp).